OWCP - OWC Pharmaceutical Research Corp.

Other OTC - Other OTC Delayed Price. Currency in USD

OWC Pharmaceutical Research Corp.

2 Ben Gurion Street
Ramat Gan 5257334
972 72 260 8004

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees9

Key Executives

NameTitlePayExercisedYear Born
Mr. Alon SinaiChief Operating Officer94kN/A1967
Dr. Yehuda BaruchChief Medical & Regulatory Affairs Officer112kN/A1957
Mr. Zvi RiterbandCEO & DirectorN/AN/A1961
Ms. Sigal Russo-GuetaChief Financial OfficerN/AN/A1978
Dr. Oron Yacoby-ZeeviChief Scientific OfficerN/AN/A1961
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing cannabis soluble tablet delivery system. In addition, it provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations. The company was formerly known as Dynamic Applications Corp. and changed its name to OWC Pharmaceutical Research Corp. in December 2014. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Ramat Gan, Israel.

Corporate Governance

OWC Pharmaceutical Research Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.